The Pfizer company logo is displayed as traders work on the floor of the New York Stock Exchange during morning trading on April 10, 2023 in New York City. 33,714 people played the daily Crossword ...

German pharmaceutical firm BioNTech, one of the first companies worldwide to develop an effective coronavirus vaccine, is looking to acquire its domestic rival CureVac, the firm said on Thursday.

Pfizer has agreed to invest 90.5 million Euros, or $95.24 million, to buy an 8.1% stake in French vaccine company Valneva as the two companies revealed advancements in their partnership to stop ...